-transparent.png){kind=logo}
Radiation therapy is generally considered to be the best primary treatment for early glottic carcinoma, with surgery reserved for local failure. In a series of 150 cases of T1 glottic carcinoma 138 were given radiation alone. In these patients the survival was 88 per cent at 3 years and 77 per cent at 5 years. Local control remained unchanged at 82 per cent after 6 years. When the results of surgery are included, local control was raised to 93 per cent. Preservation of the larynx was obtained in 92 per cent of survivors. Local extension or radiation dose levels had no influence on local control. The optimum dose could be lower than generally recommended. Voice quality after radiation therapy is superior to postsurgical laryngeal function. Since survival rates are identical, radiation therapy alone is the treatment of choice in all early glottic carcinomas.
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
January 1989,
Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
January 1976,
Revue de laryngologie - otologie - rhinologie,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
November 1997,
The Laryngoscope,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
June 1979,
Cancer,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
May 1968,
North Carolina medical journal,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
January 1958,
Medicamundi,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
September 2005,
Nihon Jibiinkoka Gakkai kaiho,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
May 1981,
La Radiologia medica,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
August 2012,
World journal of surgical oncology,
W Van Den Bogaert, and
F Ostyn, and
E Van Der Schueren
October 1979,
Tijdschrift voor ziekenverpleging,
